September 8, 2022
Tucson, Arizona – Lightsense Technology, whose multi-spectroscopic solutions address significant problems in public health like the opioid crisis, pandemics, and food safety, has recently launched an equity crowdfunding campaign on Start Engine. With the invention of the patented “Enhanced Photodetection Spectroscopy” (EPS), Lightsense has developed a completely new spectroscopy architecture for chemical, molecular, and pathogen identification. Miniaturized high-sensitivity [...]
MGI Celebrates Grand Opening of Its New State-of-the-Art Demo Lab in Japan
September 8, 2022
TOKYO, Japan – MGI Tech Co., Ltd. (MGI), a global life science leader and innovator, announced today on its first day of IPO in China the grand opening of a new demonstration laboratory in Tokyo, Japan, enhancing Japanese customers' experience. MGI has been expanding the operations of its sub-subsidiary, MGI Tech Japan Co., Ltd., by establishing [...]
Sengenics Prepares for Next Phase Growth and Welcomes Bioscience Industry Leader as New CEO
September 7, 2022
BOSTON -- Sengenics LLC, driving the discovery of next-gen biomarkers, announces that Jerry Williamson has been appointed the company’s Chief Executive Officer, effective immediately. With more than 30 years of experience in bioscience markets for life science research, diagnostics and analytical products, Mr. Williamson promises to build on Sengenics’ growth in the fields of immunology, [...]
Genomenon Integrates ClinVar Data into Mastermind to Support Clinical Decision-Making
September 7, 2022
Patient Variant Information Submitted to NIH Now Accessible Through Mastermind Genomic Search Engine ANN ARBOR, Mich. -- Genomenon, Inc., an AI-driven genomics company, has integrated all the variants and pathogenicity interpretations from the ClinVar database into the Mastermind® Genomic Search Engine. This integration combines patient variants found by genetic testing labs and submitted to ClinVar with [...]
Illumina Genomics Forum to Feature Diverse Lineup of Visionary Global Leaders
September 7, 2022
Full agenda now available for September 28–October 1 event SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the release of the full agenda for its inaugural Illumina Genomics Forum. The agenda for the four-day event can be seen here. The forum will feature over 70 speakers [...]
Biosynth Carbosynth, vivitide and Pepscan Rebrand to Biosynth
September 7, 2022
Rebranding aligns core Biosynth Group members across Complex Chemical and Peptide Manufacturing Services and Catalog Business. Staad – Biosynth Carbosynth, vivitide and Pepscan are pleased to announce today their rebranding to Biosynth to match their parent group and the launch of their site at www.biosynth.com. Biosynth is a global supplier of critical products and services to [...]
September 7, 2022
Riga, Latvia – MGI Tech Co. Ltd. (MGI), in collaboration with BGI Genomics, BGI Research and the Latvian Biomedical Research and Study Centre, has brought the 17th International Conference of Genomics (ICG-17) to Europe this year on 7-9 September in Riga, Latvia. At ICG-17, MGI introduces its new commercial sequencing chemistry HotMPS* and together with BGI STOmics, a [...]
September 7, 2022
Nearly half (44%) of top 50 biopharma companies are now involved in RNA work sparking new demand for tools purpose built for the full spectrum of RNA R&D. SAN FRANCISCO — Benchling, the R&D Cloud powering the biotechnology industry, today launched the industry’s first full set of capabilities for designing, modeling, and studying both natural and [...]
Carlyle Announces Formation of Atmas Health in Partnership with World-Class Healthcare Executives
September 7, 2022
New York, New York and Park City, Utah – Global investment firm Carlyle (NASDAQ: CG) announced today the formation of Atmas Health in partnership with long-time healthcare executives Kieran Gallahue, Jim Hinrichs, and Jim Prutow and Carlyle’s Global Healthcare team. Atmas Health, headquartered in Park City, Utah, will focus on acquiring healthcare assets within the medical [...]
September 7, 2022
WATERLOO, Ontario -- High Q Technologies Inc. is an innovative life sciences tool company providing drug hunters and structural biologists with highly sensitive, quantum-enabled EPR systems to solve historically complex problems in protein dynamics. The company is pleased to announce the appointment of Andrew Wiles as Vice President of Research and Development, reporting directly to [...]

